NetraMark Holdings Inc C.AIAI

Alternate Symbol(s): AINMF

Technology Software - Application

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.

CSE:AIAI - Post by User

NetraMark Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by retiredcfon Feb 24, 2022 6:45am

193 Views

Post# 34456800

For What It's Worth

BNN didn't post the individual link. GLTA

BUY

Nurosene Health(MEND-CSE)

22/02/2022 at 07:00pm

AI software to help drug companies to purpose different compounds to tell what's effective and what's not. Part of the small cap selloff. Continues to reach significant milestones and sign contracts. Revenue and cashflow should improve over next year. A takeout possibility.

HEALTHCARE

Bruce Campbell (2)

$0.000

Owned

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project